ArticleFrontiers in medicine2025

The impact of short-term administration of dapagliflozin on contrast-induced acute kidney injury in patients with type 2 diabetes and renal insufficiency undergoing percutaneous coronary intervention.

Shicheng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.